Joshua Gammon, from the University of Maryland, will present how locally controlled release vaccines demonstrate an enhanced immune response in mice and how this platform may be applied to therapeutic cancer vaccinations. Data demonstrating the intra-lymph node depot platform can be harnessed to inhibit immune mediated destruction of host tissues as a therapeutic treatment for autoimmune diseases will also be presented. If you're in the pharmaceutical industry, you'll want to hear more about this ground breaking research.
Do you have any questions or requests? Use this form to contact our specialists.